Search results
Results From The WOW.Com Content Network
Singapore Aero Engine Service Pte Ltd (SAESL) is a 50/50 joint venture between SIA Engineering Company (SIAEC) and Rolls-Royce (RR). Formed in 2001, SAESL is a Trent Centre of Excellence, with its core business being the maintenance, repair and overhaul (MRO) support operation of the full range of Trent engines as well as RB211 engines. SAESL ...
Rolls-Royce Holdings plc is a British multinational aerospace and defence company incorporated in February 2011. The company owns Rolls-Royce, a business established in 1904 which today designs, manufactures and distributes power systems for aviation and other industries.
In 2017, Singapore Airlines Cargo renewed its partnership with Rolls-Royce to transport Trent 1000 aircraft engines from the latter's Seletar Assembly and Test Unit in Singapore to Boeing 787 production facilities in the USA. SIA Cargo also provided charter services to carry state-of-the-art racing equipment for several global sporting events ...
SIA Engineering Company handles maintenance, repair and overhaul (MRO) business across nine countries with a portfolio of 27 joint ventures including with Boeing and Rolls-Royce. Singapore Airlines Cargo operates SIA's freighter fleet and manages the cargo-hold capacity in SIA's passenger aircraft. [7]
Rolls-Royce will also lend its aerospace and technological expertise to co-develop and enhance RP's curriculum in the areas of advanced materials and composites [32] In December 2015, RP's School of Management and Communication jointly launched the Youth Livelihood Programme (YLP) with World Vision Singapore.
The name of Rolls-Royce (1971) Limited was changed to Rolls-Royce Limited on 31 December 1977 the end of the company's financial year. The original Rolls-Royce Limited incorporated in 1906 and still in liquidation had been renamed R-R Realisations Limited [ nb 4 ] and had consented in March 1977 to the (1971) company being named Rolls-Royce ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Singapore's first publicly funded drug candidate, ETC-159, which was discovered and developed through a collaboration with Duke-NUS Graduate Medical School, advanced into Phase 1 clinical trials in July 2015. This drug targets a number of cancers, including colorectal, ovarian and pancreatic cancers, which contribute to a significant proportion ...